This is the surgical robotics question we hear most often: "Should our hospital invest in da Vinci or Mako?" The honest answer is that they solve completely different problems — but with limited capital budgets, hospitals often must choose one.
Here's the comparison that actually helps you decide.
They Solve Different Problems
The most important thing to understand: da Vinci and Mako don't compete head-to-head. They target different surgical specialties:
- da Vinci 5 — Minimally invasive soft-tissue surgery: urology (prostatectomy), gynecology, general surgery, thoracic, colorectal.
- Stryker Mako — Orthopedic joint replacement: total knee, partial knee, total hip, and expanding into spine.
If your hospital's strategic priority is building a minimally invasive surgery center of excellence, the answer is da Vinci. If you're an orthopedic-focused institution or ambulatory surgery center, the answer is Mako.
The interesting cases are hospitals with both priorities and only one budget slot.
Side-by-Side Comparison
| Dimension | da Vinci 5 | Mako SmartRobotics | |-----------|-----------|-------------------| | System Cost | $1.5-2.5M | $1.0-1.5M | | Annual Service | $150-200K | $100-150K | | Per-Procedure Cost | $800-3,500 | $400-1,200 | | Procedure Types | 70+ cleared | Knee, hip, spine | | Procedures Globally | 9M+ (all gens) | 1M+ | | Surgeon Training | 2-4 weeks + 20 cases | 1-2 weeks + 10 cases | | RoboScore | 92.3 / 100 | 89.1 / 100 | | OR Footprint | Large (multi-arm cart) | Moderate (single arm) | | Pre-op Imaging | Not required | CT scan required |
The Financial Case for da Vinci
Da Vinci's economics are volume-dependent. The high upfront cost and per-procedure instrument charges create a steep fixed-cost structure that needs volume to amortize.
Break-even analysis:
- At 200 cases/year: per-case cost ~$6,500 (barely competitive with laparoscopic)
- At 400 cases/year: per-case cost ~$3,800 (compelling)
- At 600+ cases/year: per-case cost ~$2,900 (strongly competitive)
The financial upside of da Vinci extends beyond direct procedure revenue:
- Shorter hospital stays — Robotic prostatectomy: 1 day vs. 2-3 days open. At $2,500/day, this saves $2,500-5,000 per patient.
- Fewer complications — Lower readmission rates save $10,000-25,000 per avoided readmission.
- Surgeon recruitment — Surgeons want to operate where the latest technology is available. A da Vinci program attracts top surgical talent.
- Patient acquisition — "Robotic surgery available" is a marketing message that drives patient volume.
The Financial Case for Mako
Mako's economics are simpler and more forgiving at lower volumes.
Break-even analysis:
- At 150 cases/year: per-case cost ~$3,500 (competitive with manual)
- At 300 cases/year: per-case cost ~$2,200 (strongly competitive)
- At 500+ cases/year: per-case cost ~$1,600 (excellent)
Mako's financial advantages:
- Lower entry cost — $500K-1M less upfront than da Vinci
- Lower per-case cost — Mako implants and instruments cost less per case
- Faster surgeon adoption — 1-2 week training means your surgeons are productive sooner
- Joint replacement volume is large and growing — The aging population guarantees growing demand. The US performs 1M+ knee replacements and 450K+ hip replacements annually.
- ASC migration — Joint replacements are moving to ambulatory surgery centers. Mako is well-positioned for this shift.
Clinical Outcomes
da Vinci outcomes (vs. laparoscopic/open)
The clinical evidence for da Vinci is extensive but nuanced:
- Prostatectomy — Robotic has clear advantages: less blood loss, shorter stay, comparable cancer outcomes, better continence recovery at 12 months.
- Hysterectomy — Robotic comparable to laparoscopic for benign cases; advantages in complex cases (endometriosis, large uteri).
- General surgery — Mixed evidence. Robotic hernia repair and cholecystectomy show comparable outcomes to laparoscopic with higher cost.
Mako outcomes (vs. manual joint replacement)
- Implant alignment — Studies show 2x better alignment accuracy with Mako vs. manual. This matters because misaligned implants fail faster.
- Bone preservation — AccuStop haptic boundaries prevent over-resection. More native bone preserved = easier revision if ever needed.
- Soft tissue protection — Reduced soft tissue damage correlates with faster rehabilitation.
- Patient satisfaction — Studies report higher satisfaction scores at 6 months and 2 years post-operatively.
The Decision Framework
Choose da Vinci if:
- Your hospital performs 300+ eligible MIS procedures per year (prostatectomy, hysterectomy, thoracic, colorectal)
- You're building or expanding a minimally invasive surgery program
- Surgeon recruitment is a strategic priority
- You have the OR space for the system (ceiling height, floor space)
- Your payer mix supports the higher per-case cost
Choose Mako if:
- You're an orthopedic-focused institution or ASC
- You perform 200+ joint replacements per year
- Your surgeons want improved implant accuracy
- Budget is a constraint (lower entry and per-case costs)
- You want faster time to surgeon proficiency
Consider both if:
- You're a large health system with capital to invest in multiple platforms
- Your surgical volume justifies both systems
- You have dedicated OR space and service budgets for two robotic platforms
Common Mistakes in Surgical Robot Purchasing
-
Buying on prestige alone — "Our competitor hospital has da Vinci" isn't a business case. Calculate your specific volume-based economics.
-
Ignoring per-procedure costs — The purchase price is 30-40% of 5-year TCO. Instruments, service contracts, and training are the rest.
-
Overestimating adoption speed — Not every surgeon will embrace robotics. Survey your surgical staff before purchasing. A $2M system used by 2 surgeons is a bad investment.
-
Neglecting OR workflow impact — Robotic cases take 15-30 minutes longer than manual (including setup). If your ORs are at capacity, adding robotic cases means fewer total cases per day initially.
-
Skipping the site visit — Visit a hospital that has deployed the system you're considering. Watch a case. Talk to the surgical team. No brochure or demo replaces seeing the system in real clinical use.
Compare the total cost of both systems using our TCO Calculator.
Frequently Asked Questions
Can a hospital have both da Vinci and Mako?
Yes — many large health systems operate both platforms since they serve completely different surgical specialties. The da Vinci handles minimally invasive soft-tissue procedures while Mako handles orthopedic joint replacements. There's no clinical overlap. The constraint is capital budget and OR scheduling, not technology compatibility.
Which surgical robot has the faster ROI?
Mako typically achieves faster ROI due to lower upfront cost ($1.0-1.5M vs. $1.5-2.5M), lower per-procedure costs, and the large addressable market of joint replacement procedures. Most Mako deployments break even in 2-3 years. Da Vinci break-even is typically 3-4 years but depends heavily on case volume.
Is da Vinci being replaced by newer surgical robots like Hugo?
Not yet. Medtronic's Hugo RAS is a credible challenger but has fewer FDA clearances, a smaller evidence base, and no installed base comparable to da Vinci's 9 million+ procedures. Hugo may capture market share over the next 3-5 years, particularly in price-sensitive markets, but da Vinci remains the dominant platform for soft-tissue robotic surgery in 2026.
What training is required for surgeons using these systems?
Da Vinci requires 2-4 weeks of intensive training including simulation, dry lab, and cadaver lab, followed by 10-20 proctored clinical cases. Total time to independent operation: 2-4 months. Mako requires 1-2 weeks of training plus approximately 10 proctored cases. Surgeons with existing joint replacement experience often feel comfortable within 15-20 total cases.
Which system is better for a new ambulatory surgery center?
Mako is better suited for ASCs due to its lower cost, orthopedic focus (joint replacements are the procedures migrating fastest to ASCs), and smaller OR footprint. Da Vinci is generally a hospital-based system — the complexity of its procedures and the need for overnight stay capability make it less common in ASC settings.